We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

141 hedge funds and large institutions have $665M invested in Immunogen Inc in 2015 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more call options, than puts

Call options by funds: $7.88M | Put options by funds: $3.1M

67% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 18

64% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 33

57% more capital invested

Capital invested by funds: $423M → $665M (+$242M)

8% more funds holding

Funds holding: 131 → 141 (+10)

Holders
141
Holders Change
+10
Holders Change %
+7.63%
% of All Funds
3.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
54
Reduced
33
Closed
18
Calls
$7.88M
Puts
$3.1M
Net Calls
+$4.79M
Net Calls Change
-$2.41M

Top Buyers

Rank Fund Capital Flow
1
ClearBridge Investments
ClearBridge Investments
New York
+$21.8M
2
State Street
State Street
Massachusetts
+$7.89M
3
BBA
Baker Bros. Advisors
New York
+$7.24M
4
Primecap Management
Primecap Management
California
+$3.49M
5
Wells Fargo
Wells Fargo
California
+$3.09M

Top Sellers

Rank Fund Capital Flow
1
BIM
Bogle Investment Management
Massachusetts
-$4.71M
2
Millennium Management
Millennium Management
New York
-$3.98M
3
BB
BB Biotech
Switzerland
-$2.9M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.81M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$2.92M +$152K +20,989 +7%
Charles Schwab
27
Charles Schwab
California
$2.46M +$95.7K +13,206 +5%
BTS
28
BB&T Securities
Virginia
$2.45M +$84.8K +11,710 +75%
Barclays
29
Barclays
United Kingdom
$2.35M +$929K +128,294 +77%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$2.12M -$2.81M -387,994 -62%
BIM
31
BlackRock Investment Management
Delaware
$2.11M +$13.4K +1,851 +0.8%
MIG
32
Mariner Investment Group
New York
$2.1M -$171K -23,600 -9%
Goldman Sachs
33
Goldman Sachs
New York
$1.94M -$73.2K -10,101 -4%
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$1.76M +$1.42M +196,428 New
RFC
35
Russell Frank Company
Washington
$1.75M +$1.41M +194,955 New
LK
36
Lumbard & Kellner
New Hampshire
$1.5M +$420K +58,030 +53%
AllianceBernstein
37
AllianceBernstein
Tennessee
$1.47M – – –
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$1.4M -$18.1K -2,500 -2%
Citigroup
39
Citigroup
New York
$1.36M +$376K +51,904 +52%
Prudential Financial
40
Prudential Financial
New Jersey
$1.32M +$679K +93,800 +173%
Natixis Advisors
41
Natixis Advisors
Massachusetts
$1.29M +$376K +51,894 +56%
TFCP
42
Twin Focus Capital Partners
Massachusetts
$1.26M +$3.18K +439 +0.3%
TA
43
Teachers Advisors
New York
$1.23M +$115K +15,872 +13%
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$1.2M -$2.35M -323,880 -71%
CS
45
Credit Suisse
Switzerland
$1.15M -$420K -57,948 -31%
Swiss National Bank
46
Swiss National Bank
Switzerland
$1.09M +$188K +26,000 +27%
USAA
47
United Services Automobile Association
Texas
$1.07M +$37.7K +5,200 +5%
TC
48
TFS Capital
Pennsylvania
$933K +$356K +49,177 +89%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$874K – – –
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$848K +$108K +14,850 +19%
1
2
3 4 5

IMGN Hedge Fund Activity: Q1 2015 in Review

141 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2015, worth a combined $665M — up 57% from $423M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new IMGN positions and 18 closed out — a net gain of 12 holders — while 54 added to existing stakes and 33 trimmed.

The largest buyer was ClearBridge Investments, adding an estimated $21.8M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $4.71M sold.

  • 141 institutional investors held Immunogen Inc (IMGN) as of Q1 2015, up from 131 in Q4 2014.
  • Funds reported $665M of Immunogen Inc stock for Q1 2015, up 57% quarter-over-quarter.
  • 30 funds opened new Immunogen Inc positions in Q1 2015 and 18 closed out, a net change of +12 holders.
  • The largest Immunogen Inc buyer in Q1 2015 was ClearBridge Investments, an estimated $21.8M added.
  • The largest Immunogen Inc seller in Q1 2015 was Bogle Investment Management, an estimated $4.71M sold.

Based on aggregated 13F filings for Q1 2015.